Logo Image
News|Articles|January 14, 2025

MHE Publication

  • MHE January 2025
  • Volume 35
  • Issue 1

Out-of-Pocket Limits Increase Utilization | Predictions for 2025

Jerilyn Arneson, Pharm. D, co-founder and officer of the National Association of Medication Access & Patient Advocacy, gives her 2025 prediction.

The lower out-of-pocket maximum in Medicare Part D plans might encourage some patients to use more healthcare services, including prescription drugs, that they previously couldn’t afford and, thus, never had filled. This increased utilization could lead to more people hitting the $2,000 limit and increasing the demand for foundation assistance.

Articles in this issue

over 1 year ago

Many Believe RFK Jr.’s Views on Vaccination Are Dangerous and Other Findings | MHE State of the Industry Survey Results, Part 1

over 1 year ago

Lab Power | Predictions for 2025

over 1 year ago

Here we are Now, Enable us | Predictions for 2025

over 1 year ago

Advancing Care Coordination, Equity and AI Integration | Predictions for 2025

over 1 year ago

GLP-1s in a More Mode: More Indications, More Access | Predictions for 2025

over 1 year ago

Telehealth, the Fully Hybridized Version | Prediction for 2025

over 1 year ago

Cybersecurity on Health Plan Radar | Predictions for 2025

over 1 year ago

Simulacra of Data as an Answer | Predictions for 2025

over 1 year ago

AI Soups up Payer Operations | Predictions for 2025

over 1 year ago

Digital Lifeline | Predictions for 2025

Related Content

Latest CME

Medical Crossfire®: ADCs and Bispecifics in Lung Cancer – Hype, Hope, or a New Standard of Care?
In-Person + Virtual Event

Medical Crossfire®: ADCs and Bispecifics in Lung Cancer – Hype, Hope, or a New Standard of Care?

September 12, 2026

View more
𝘔𝘌𝘛 Alterations in NSCLC: Applying Diagnostic Advances and Targeted Therapies in a New Era of Treatment
Video

𝘔𝘌𝘛 Alterations in NSCLC: Applying Diagnostic Advances and Targeted Therapies in a New Era of Treatment

Jonathan Goldman, MD; Sanja Dacic, MD, PhD; Deborah Doroshow, MD, PhD; Anne S. Tsao, MD, MBA

View more
27th Annual International Lung Cancer Congress®
Video

27th Annual International Lung Cancer Congress®

Roy S. Herbst, MD, PhD; Sandip Patel, MD, FASCO; Heather A. Wakelee, MD, FASCO

View more
Tennessee Oncology Practice Society
Virtual Event

Tennessee Oncology Practice Society

2 Sessions are Available!

View more
Community Practice Connections™: DLL3-Targeting Bispecific Antibodies for Small Cell Lung Cancer—From Innovation to Practice
Multimedia

Community Practice Connections™: DLL3-Targeting Bispecific Antibodies for Small Cell Lung Cancer—From Innovation to Practice

Jacob Sands, MD; Anne Chiang, MD, PhD

View more
Hot Seat: Converging Lines in the Management of RAS-Altered Cancers
Video

Hot Seat: Converging Lines in the Management of RAS-Altered Cancers

Shubham Pant, MD, MBBS; Alison Schram, MD; Helena Yu, MD

View more
From Suspicion to Stabilization: Early Recognition and Treatment of Paraneoplastic LEMS
Video

From Suspicion to Stabilization: Early Recognition and Treatment of Paraneoplastic LEMS

Charu Aggarwal, MD, MPH, FASCO; Erminia Massarelli, MD, PhD, MS; Ruham Nasany, MD

View more
Show Me the Data™: Incorporating the Latest Advances in Immunotherapy and EGFR-Targeted Treatments for Resectable, Early-Stage NSCLC
Video

Show Me the Data™: Incorporating the Latest Advances in Immunotherapy and EGFR-Targeted Treatments for Resectable, Early-Stage NSCLC

Mara Antonoff, MD, FACS; Laura Alder, MD; Stephanie Worrell, MD, FACS

View more